NEW YORK,
May 4, 2020 /PRNewswire/ --
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today
announced that the distribution date for the previously announced
distribution to our stockholders of shares of Hoth Therapeutics,
Inc. ("Hoth") will not be taking place today, May 4, 2020, because of the requirement that the
shares be registered prior to distribution. AIkido will provide a
distribution date for the distribution of the shares promptly once
the registration statement is declared effective. The Company is
waiting on ("Hoth") to seek acceleration of the registration
statement, which is a prerequisite for distribution. We hope for
this to be done shortly and will update shareholders as soon as
possible. The record date has not changed and individuals who were
shareholders at 4pm on April 30th, 2020 will be receiving the
dividend. No further action is required.
About AIkido
AIkido was initially formed in 1967 and is a biotechnology
company with a diverse portfolio of small-molecule anti-cancer
therapeutics. The Company's platform consists of patented
technology from leading universities and researchers and we are
currently in the process of developing an innovative therapeutic
drug platform through strong partnerships with world renowned
educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of
therapeutics includes therapies for pancreatic cancer, acute
myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In
addition, we are constantly seeking to grow our pipeline to treat
unmet medical needs in oncology
Forward-Looking Statements
Certain statements in this press release constitute
"forward-looking statements" within the meaning of the federal
securities laws. Words such as "may," "might," "will," "should,"
"believe," "expect," "anticipate," "estimate," "continue,"
"predict," "forecast," "project," "plan," "intend" or similar
expressions, or statements regarding intent, belief, or current
expectations, are forward-looking statements. While the Company
believes these forward-looking statements are reasonable, undue
reliance should not be placed on any such forward-looking
statements, which are based on information available to us on the
date of this release. These forward looking statements are based
upon current estimates and assumptions and are subject to various
risks and uncertainties, including without limitation those set
forth in the Company's filings with the SEC, not limited to Risk
Factors relating to its business contained therein. Thus, actual
results could be materially different. The Company expressly
disclaims any obligation to update or alter statements whether as a
result of new information, future events or otherwise, except as
required by law.
Contact :
|
|
|
|
Investor
Relations:
|
Hayden IR
|
|
Brett Maas, Managing
Partner
|
|
Phone: (646)
536-7331
|
|
Email:
brett@haydenir.com
|
|
www.haydenir.com
|
|
|
AIkido:
|
Phone:
212-745-1373
|
|
Email:
investorrelations@AIkido.com
|
|
www.AIkido.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aikido-pharma-inc-provides-update-on-anticipated-distribution-date-for-hoth-dividend-distribution-301052305.html
SOURCE AIkido Pharma Inc.